PRIOTHERA SAS
🇫🇷France
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Priothera SAS
- Target Recruit Count
- 366
- Registration Number
- NCT05429632
- Locations
- 🇺🇸
University of Alabama Hospital (UAB Hospital), Birmingham, Alabama, United States
🇺🇸Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸City of Hope Comprehensive Cancer Center - Duarte, Duarte, California, United States
News
No news found